Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over the United States' request for sensitive information.
The decision became public after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson later stated that the United States was demanding access to health data for scientific study and commercial gain but was not willing to guarantee the benefits from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for continued talks to secure a deal agreeable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court blocked a related health funding agreement after concerns were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost openness and accountability.
According to reports, 16 African countries have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Effectively, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our citizens should a future disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.
"This system is intended to guarantee that when a country contributes its data, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome further dialogue with our US partners on how future collaboration might be arranged in a way that respects the sovereignty and dignity of both nations."
Medical Community Response
Medical experts stated it understood the official position, but recommended that negotiations need to persist considering much of the country's Aids initiatives relied on international support.
"If technical issues arise, including those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.
The situation highlights the ongoing debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.